Literature DB >> 21659545

Btk is a positive regulator in the TREM-1/DAP12 signaling pathway.

Tereza Ormsby1, Eva Schlecker, Janina Ferdin, Anja Sibylle Tessarz, Pavla Angelisová, Afitap Derya Köprülü, Michael Borte, Klaus Warnatz, Ilka Schulze, Wilfried Ellmeier, Václav Horejsí, Adelheid Cerwenka.   

Abstract

The triggering receptor expressed on myeloid cells 1 (TREM-1) has been implicated in the production of proinflammatory cytokines and chemokines during bacterial infection and sepsis. For downstream signal transduction, TREM-1 is coupled to the ITAM-containing adaptor DAP12. Here, we demonstrate that Bruton tyrosine kinase (Btk), a member of the Tec kinases, becomes phosphorylated upon TREM-1 triggering. In U937-derived cell lines, in which expression of Btk was diminished by shRNA-mediated knockdown, phosphorylation of Erk1/2 and PLCγ1 and Ca²⁺ mobilization were reduced after TREM-1 stimulation. Importantly, TREM-1-induced production of the pro-inflammatory cytokines, TNF-α and IL-8, and up-regulation of activation/differentiation cell surface markers were impaired in Btk knockdown cells. Similar results were obtained upon TREM-1 stimulation of BMDCs of Btk(-/-) mice. The analysis of cells containing Btk mutants revealed that intact membrane localization and a functional kinase domain were required for TREM-1-mediated signaling. Finally, after TREM-1 engagement, TNF-α production by PBMCs was reduced in the majority of patients suffering from X-linked agammaglobulinemia (XLA), a rare hereditary disease caused by mutations in the BTK gene. In conclusion, our data identify Btk as a positive regulator in the ITAM-mediated TREM-1/DAP12 pathway and suggest its implication in inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21659545     DOI: 10.1182/blood-2010-11-317016

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation.

Authors:  Nicole Stadler; Astrid Hasibeder; Pamela Aranda Lopez; Daniel Teschner; Alexander Desuki; Oliver Kriege; Alexander N R Weber; Christoph Schulz; Christian Michel; Georg Heβ; Markus P Radsak
Journal:  Haematologica       Date:  2017-01-25       Impact factor: 9.941

2.  Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy.

Authors:  Fabio Da Roit; Patrick J Engelberts; Ronald P Taylor; Esther C W Breij; Giuseppe Gritti; Alessandro Rambaldi; Martino Introna; Paul W H I Parren; Frank J Beurskens; Josée Golay
Journal:  Haematologica       Date:  2014-10-24       Impact factor: 9.941

3.  TREM-1 promotes survival during Klebsiella pneumoniae liver abscess in mice.

Authors:  Yi-Tsung Lin; Kai-Yu Tseng; Yi-Chen Yeh; Fu-Chen Yang; Chang-Phone Fung; Nien-Jung Chen
Journal:  Infect Immun       Date:  2014-01-06       Impact factor: 3.441

4.  Tyrosine kinase Btk is required for NK cell activation.

Authors:  Yan Bao; Jian Zheng; Chaofeng Han; Jing Jin; Huanxing Han; Yinping Liu; Yu-Lung Lau; Wenwei Tu; Xuetao Cao
Journal:  J Biol Chem       Date:  2012-05-15       Impact factor: 5.157

5.  Myeloid cell-like transcript 2 is related to liver inflammation and the pathogenesis of hepatitis B via the involvement of CD8+T cell activation.

Authors:  Jun-Chi Xu; Fei Gao; Yi-An Liu; Xiao-Long Zhang; Hui Chen; Xiao-Yan Zhu; Hua-Feng Song; Feng Qian; Ming Li; Chen Yang; Chuan-Wu Zhu; Ping Xu
Journal:  Clin Exp Med       Date:  2018-10-25       Impact factor: 3.984

6.  Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy.

Authors:  Cheng-Ying Chu; Yi-Ching Lee; Cheng-Han Hsieh; Chi-Tai Yeh; Tsu-Yi Chao; Po-Hung Chen; I-Hsuan Lin; Tsung-Han Hsieh; Jing-Wen Shih; Chia-Hsiung Cheng; Che-Chang Chang; Ping-Sheng Lin; Yuan-Li Huang; Tsung-Ming Chen; Yun Yen; David K Ann; Hsing-Jien Kung
Journal:  Theranostics       Date:  2021-01-25       Impact factor: 11.556

7.  Bruton's Tyrosine Kinase (BTK) and Vav1 contribute to Dectin1-dependent phagocytosis of Candida albicans in macrophages.

Authors:  Karin Strijbis; Fikadu G Tafesse; Gregory D Fairn; Martin D Witte; Stephanie K Dougan; Nicki Watson; Eric Spooner; Alexandre Esteban; Valmik K Vyas; Gerald R Fink; Sergio Grinstein; Hidde L Ploegh
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

Review 8.  Altered bone biology in psoriatic arthritis.

Authors:  Homaira Rahimi; Christopher T Ritchlin
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

Review 9.  Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies.

Authors:  Stefan F H Neys; Rudi W Hendriks; Odilia B J Corneth
Journal:  Front Cell Dev Biol       Date:  2021-06-04

10.  Accuracy of triggering receptor expressed on myeloid cells 1 in diagnosis and prognosis of acute myocardial infarction: a prospective cohort study.

Authors:  Zhenjun Ji; Rui Zhang; Mingming Yang; Wenjie Zuo; Yuyu Yao; Yangyang Qu; Yamin Su; Zhuyuan Liu; Ziran Gu; Genshan Ma
Journal:  PeerJ       Date:  2021-06-22       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.